VILDIABATE PIO : Diabetic Medicines: Benefits and Side Effects

VILDIABATE PIO

Vildagliptin 50 mg & Pioglitazone Hydrochloride 15 mg

VILDIABATE PIO is a combination medication consisting of Vildagliptin 50 mg and Pioglitazone Hydrochloride 15 mg. This medication works by improving blood sugar control in adults who are not adequately controlled by diet and exercise alone.

Mechanism of Action
Vildagliptin: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones, which helps to regulate blood glucose levels by increasing insulin release and decreasing glucagon secretion.
Pioglitazone Hydrochloride: Pioglitazone belongs to a class of drugs known as thiazolidinediones. It improves insulin sensitivity by acting as a selective agonist for peroxisome proliferator-activated receptor-gamma (PPAR-γ). This action reduces insulin resistance in the liver and peripheral tissues.
Uses
Type 2 Diabetes Mellitus: VILDIABATE PIO is indicated for the management of type 2 diabetes mellitus, particularly in patients who do not achieve sufficient blood sugar control with diet, exercise, and other oral antidiabetic agents.
Dosage and Administration
Standard Dosage: The typical dosage is one tablet taken once or twice daily, depending on the patient's response and the doctor's prescription.
Benefits
Blood Sugar Control: The combination of Vildagliptin and Pioglitazone provides a dual mechanism to effectively lower blood glucose levels.
Improved Insulin Sensitivity: Enhances the body's response to insulin, making it easier to control blood sugar levels.
Convenience: Combining two medications in one tablet simplifies the medication regimen, improving patient compliance.
Side Effects
Common Side Effects: Headache, dizziness, upper respiratory tract infections, weight gain, and edema.
Serious Side Effects: Hypoglycemia, heart failure, liver dysfunction, and bladder cancer (rare but significant).
Precautions
Liver Function: Regular monitoring of liver function tests is recommended due to the risk of hepatic dysfunction.
Heart Failure: Pioglitazone may cause or exacerbate heart failure. 
Bladder Cancer: There is a potential risk of bladder cancer with long-term use of Pioglitazone.
Drug Interactions
Insulin: Concurrent use with insulin may increase the risk of hypoglycemia.
Oral Contraceptives: Pioglitazone can reduce the efficacy of oral contraceptives, necessitating alternative or additional contraceptive measures.
Ketoconazole: May increase the effects of Vildagliptin, requiring dose adjustments.
Conclusion
VILDIABATE PIO (Vildagliptin 50 mg & Pioglitazone Hydrochloride 15 mg) is an effective medication for managing type 2 diabetes mellitus. Its dual-action approach improves blood sugar control and insulin sensitivity, making it a valuable option for patients who need additional help beyond diet and exercise. Regular monitoring and adherence to prescribed dosages can help mitigate potential side effects and enhance therapeutic outcomes. Always consult with a healthcare provider before starting or adjusting any medication regimen.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company's mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it's advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and  sterispharma  Order Now Sterispharma's extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488

For further information:

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488

Buy Now: